Something went wrong! Please try again later.
Don't have an account? Click here to register
Get access to regular updates from PE HUB
Which other brands would you like to receive newsletters from:
A link has been emailed to you - check your inbox.
Drug developer Akeso has raised nearly $150 million in Series D financing. Loyal Valley Capital and Sino Biopharmaceutical Co. Ltd led the round.
Source: Press Release